{
    "author_highlights": [
        {
            "endOffset": 6746,
            "sentence": "Chagas disease is responsible for 10,600 deaths and 0.6 million DALYS annually.",
            "startOffset": 6667
        },
        {
            "endOffset": 6810,
            "sentence": "Chemotherapy requires timely diagnosis and long-term treatment.",
            "startOffset": 6747
        },
        {
            "endOffset": 6883,
            "sentence": "Vaccine-linked chemotherapy will combine therapeutic vaccine with drugs.",
            "startOffset": 6811
        },
        {
            "endOffset": 6956,
            "sentence": "Recombinant protein-based and DNA-based vaccine candidates are reviewed.",
            "startOffset": 6884
        }
    ],
    "bib_entries": {
        "bib0275": {
            "authors": [
                {
                    "first": "Caryn",
                    "initial": "C.",
                    "last": "Bern"
                }
            ],
            "doi": "10.1056/NEJMc1510996",
            "firstpage": "1882",
            "issn": "00284793",
            "pmid": "26535522",
            "pub_year": 2015,
            "title": "The author replies",
            "volume": "373"
        },
        "bib0280": null,
        "bib0285": {
            "authors": [
                {
                    "first": "Peter J.",
                    "initial": "P.J.",
                    "last": "Hotez"
                },
                {
                    "first": "Maria Elena",
                    "initial": "M.E.",
                    "last": "Bottazzi"
                },
                {
                    "first": "Carlos",
                    "initial": "C.",
                    "last": "Franco-Paredes"
                },
                {
                    "first": "Steven K.",
                    "initial": "S.K.",
                    "last": "Ault"
                },
                {
                    "first": "Mirta Roses",
                    "initial": "M.R.",
                    "last": "Periago"
                }
            ],
            "doi": "10.1371/journal.pntd.0000300",
            "pmid": "18820747",
            "pub_year": 2008,
            "title": "The neglected tropical diseases of Latin America and the Caribbean: A review of disease burden and distribution and a roadmap for control and elimination",
            "volume": "2"
        },
        "bib0290": {
            "authors": [
                {
                    "first": "Peter J.",
                    "initial": "P.J.",
                    "last": "Hotez"
                },
                {
                    "first": "Miriam",
                    "initial": "M.",
                    "last": "Alvarado"
                },
                {
                    "first": "Mar\u00eda Gloria",
                    "initial": "M.G.",
                    "last": "Bas\u00e1\u00f1ez"
                },
                {
                    "first": "Ian",
                    "initial": "I.",
                    "last": "Bolliger"
                },
                {
                    "first": "Rupert",
                    "initial": "R.",
                    "last": "Bourne"
                },
                {
                    "first": "Michel",
                    "initial": "M.",
                    "last": "Boussinesq"
                },
                {
                    "first": "Simon J.",
                    "initial": "S.J.",
                    "last": "Brooker"
                },
                {
                    "first": "Ami Shah",
                    "initial": "A.S.",
                    "last": "Brown"
                },
                {
                    "first": "Geoffrey",
                    "initial": "G.",
                    "last": "Buckle"
                },
                {
                    "first": "Christine M.",
                    "initial": "C.M.",
                    "last": "Budke"
                },
                {
                    "first": "H\u00e9l\u00e8ne",
                    "initial": "H.",
                    "last": "Carabin"
                },
                {
                    "first": "Luc E.",
                    "initial": "L.E.",
                    "last": "Coffeng"
                },
                {
                    "first": "Eric M.",
                    "initial": "E.M.",
                    "last": "F\u00e8vre"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "F\u00fcrst"
                },
                {
                    "first": "Yara A.",
                    "initial": "Y.A.",
                    "last": "Halasa"
                },
                {
                    "first": "Rashmi",
                    "initial": "R.",
                    "last": "Jasrasaria"
                },
                {
                    "first": "Nicole E.",
                    "initial": "N.E.",
                    "last": "Johns"
                },
                {
                    "first": "Jennifer",
                    "initial": "J.",
                    "last": "Keiser"
                },
                {
                    "first": "Charles H.",
                    "initial": "C.H.",
                    "last": "King"
                },
                {
                    "first": "Rafael",
                    "initial": "R.",
                    "last": "Lozano"
                },
                {
                    "first": "Michele E.",
                    "initial": "M.E.",
                    "last": "Murdoch"
                },
                {
                    "first": "Simon",
                    "initial": "S.",
                    "last": "O'Hanlon"
                },
                {
                    "first": "S\u00e9bastien D.S.",
                    "initial": "S.D.S.",
                    "last": "Pion"
                },
                {
                    "first": "Rachel L.",
                    "initial": "R.L.",
                    "last": "Pullan"
                },
                {
                    "first": "Kapa D.",
                    "initial": "K.D.",
                    "last": "Ramaiah"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Roberts"
                },
                {
                    "first": "Donald S.",
                    "initial": "D.S.",
                    "last": "Shepard"
                },
                {
                    "first": "Jennifer L.",
                    "initial": "J.L.",
                    "last": "Smith"
                },
                {
                    "first": "Wilma A.",
                    "initial": "W.A.",
                    "last": "Stolk"
                },
                {
                    "first": "Eduardo A.",
                    "initial": "E.A.",
                    "last": "Undurraga"
                },
                {
                    "first": "J\u00fcrg",
                    "initial": "J.",
                    "last": "Utzinger"
                },
                {
                    "first": "Mengru",
                    "initial": "M.",
                    "last": "Wang"
                },
                {
                    "first": "Christopher J.L.",
                    "initial": "C.J.L.",
                    "last": "Murray"
                },
                {
                    "first": "Mohsen",
                    "initial": "M.",
                    "last": "Naghavi"
                }
            ],
            "doi": "10.1371/journal.pntd.0002865",
            "issn": "19352727",
            "pub_year": 2014,
            "title": "The Global Burden of Disease Study 2010: Interpretation and Implications for the Neglected Tropical Diseases",
            "volume": "8"
        },
        "bib0295": null,
        "bib0300": {
            "authors": [
                {
                    "first": "Kevin M.",
                    "initial": "K.M.",
                    "last": "Bonney"
                }
            ],
            "doi": "10.1051/parasite/2014012",
            "issn": "1252607X",
            "pmid": "24626257",
            "pub_year": 2014,
            "title": "Chagas disease in the 21st Century: A public health success or an emerging threat?",
            "volume": "21"
        },
        "bib0305": {
            "authors": [],
            "firstpage": "33",
            "issn": "00498114",
            "lastpage": "43",
            "pmid": "25671846",
            "pub_year": 2015,
            "title": "Chagas disease in Latin America: an epidemiological update based on 2010 estimates",
            "volume": "90"
        },
        "bib0310": {
            "authors": [
                {
                    "first": "Gabriel A.",
                    "initial": "G.A.",
                    "last": "Schmunis"
                },
                {
                    "first": "Zaida E.",
                    "initial": "Z.E.",
                    "last": "Yadon"
                }
            ],
            "doi": "10.1016/j.actatropica.2009.11.003",
            "firstpage": "14",
            "issn": "0001706X",
            "lastpage": "21",
            "pmid": "19932071",
            "pub_year": 2010,
            "title": "Chagas disease: A Latin American health problem becoming a world health problem",
            "volume": "115"
        },
        "bib0315": {
            "authors": [
                {
                    "first": "Joaquim",
                    "initial": "J.",
                    "last": "Gascon"
                },
                {
                    "first": "Caryn",
                    "initial": "C.",
                    "last": "Bern"
                },
                {
                    "first": "Mar\u00eda Jes\u00fas",
                    "initial": "M.J.",
                    "last": "Pinazo"
                }
            ],
            "doi": "10.1016/j.actatropica.2009.07.019",
            "firstpage": "22",
            "issn": "0001706X",
            "lastpage": "27",
            "pmid": "19646412",
            "pub_year": 2010,
            "title": "Chagas disease in Spain, the United States and other non-endemic countries",
            "volume": "115"
        },
        "bib0320": {
            "authors": [
                {
                    "first": "Melissa N.",
                    "initial": "M.N.",
                    "last": "Garcia"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Aguilar"
                },
                {
                    "first": "Rodion",
                    "initial": "R.",
                    "last": "Gorchakov"
                },
                {
                    "first": "Susan N.",
                    "initial": "S.N.",
                    "last": "Rossmann"
                },
                {
                    "first": "Susan P.",
                    "initial": "S.P.",
                    "last": "Montgomery"
                },
                {
                    "first": "Hilda",
                    "initial": "H.",
                    "last": "Rivera"
                },
                {
                    "first": "Laila",
                    "initial": "L.",
                    "last": "Woc-Colburn"
                },
                {
                    "first": "Peter J.",
                    "initial": "P.J.",
                    "last": "Hotez"
                },
                {
                    "first": "Kristy O.",
                    "initial": "K.O.",
                    "last": "Murray"
                }
            ],
            "doi": "10.4269/ajtmh.14-0238",
            "firstpage": "325",
            "issn": "00029637",
            "lastpage": "330",
            "pmid": "25371187",
            "pub_year": 2015,
            "title": "Case report: Evidence of Autochthonous chagas disease in Southeastern Texas",
            "volume": "92"
        },
        "bib0325": {
            "authors": [
                {
                    "first": "Melissa N.",
                    "initial": "M.N.",
                    "last": "Garcia"
                },
                {
                    "first": "Kristy O.",
                    "initial": "K.O.",
                    "last": "Murray"
                },
                {
                    "first": "Peter J.",
                    "initial": "P.J.",
                    "last": "Hotez"
                },
                {
                    "first": "Susan N.",
                    "initial": "S.N.",
                    "last": "Rossmann"
                },
                {
                    "first": "Rodion",
                    "initial": "R.",
                    "last": "Gorchakov"
                },
                {
                    "first": "Alejandra",
                    "initial": "A.",
                    "last": "Ontiveros"
                },
                {
                    "first": "Laila",
                    "initial": "L.",
                    "last": "Woc-Colburn"
                },
                {
                    "first": "Maria Elena",
                    "initial": "M.E.",
                    "last": "Bottazzi"
                },
                {
                    "first": "Charles E.",
                    "initial": "C.E.",
                    "last": "Rhodes"
                },
                {
                    "first": "Christie M.",
                    "initial": "C.M.",
                    "last": "Ballantyne"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Aguilar"
                }
            ],
            "doi": "10.1016/j.amjcard.2014.09.050",
            "firstpage": "113",
            "issn": "00029149",
            "lastpage": "117",
            "pmid": "25456877",
            "pub_year": 2015,
            "title": "Development of Chagas cardiac manifestations among texas blood donors",
            "volume": "115"
        },
        "bib0330": {
            "authors": [
                {
                    "first": "Jennifer M.",
                    "initial": "J.M.",
                    "last": "Manne"
                },
                {
                    "first": "Callae S.",
                    "initial": "C.S.",
                    "last": "Snively"
                },
                {
                    "first": "Janine M.",
                    "initial": "J.M.",
                    "last": "Ramsey"
                },
                {
                    "first": "Marco Ocampo",
                    "initial": "M.O.",
                    "last": "Salgado"
                },
                {
                    "first": "Till",
                    "initial": "T.",
                    "last": "B\u00e4rnighausen"
                },
                {
                    "first": "Michael R.",
                    "initial": "M.R.",
                    "last": "Reich"
                }
            ],
            "doi": "10.1371/journal.pntd.0002488",
            "issn": "19352727",
            "pmid": "24147169",
            "pub_year": 2013,
            "title": "Barriers to Treatment Access for Chagas Disease in Mexico",
            "volume": "7"
        },
        "bib0335": {
            "authors": [
                {
                    "first": "Peter J.",
                    "initial": "P.J.",
                    "last": "Hotez"
                }
            ],
            "doi": "10.1371/journal.pntd.0003672",
            "firstpage": "1",
            "issn": "19352727",
            "lastpage": "5",
            "pub_year": 2015,
            "title": "Blue marble health redux: Neglected tropical diseases and human development in the group of 20 (G20) nations and Nigeria",
            "volume": "9"
        },
        "bib0340": {
            "authors": [
                {
                    "first": "Bruce Y.",
                    "initial": "B.Y.",
                    "last": "Lee"
                },
                {
                    "first": "Kristina M.",
                    "initial": "K.M.",
                    "last": "Bacon"
                },
                {
                    "first": "Maria Elena",
                    "initial": "M.E.",
                    "last": "Bottazzi"
                },
                {
                    "first": "Peter J.",
                    "initial": "P.J.",
                    "last": "Hotez"
                }
            ],
            "doi": "10.1016/S1473-3099(13)70002-1",
            "firstpage": "342",
            "issn": "14733099",
            "lastpage": "348",
            "pmid": "23395248",
            "pub_year": 2013,
            "title": "Global economic burden of Chagas disease: A computational simulation model",
            "volume": "13"
        },
        "bib0345": {
            "authors": [
                {
                    "first": "Bruce Y.",
                    "initial": "B.Y.",
                    "last": "Lee"
                },
                {
                    "first": "Kristina M.",
                    "initial": "K.M.",
                    "last": "Bacon"
                },
                {
                    "first": "Angela R.",
                    "initial": "A.R.",
                    "last": "Wateska"
                },
                {
                    "first": "Maria Elena",
                    "initial": "M.E.",
                    "last": "Bottazzi"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Dumonteil"
                },
                {
                    "first": "Peter J.",
                    "initial": "P.J.",
                    "last": "Hotez"
                }
            ],
            "doi": "10.4161/hv.20966",
            "firstpage": "1293",
            "issn": "2164554X",
            "lastpage": "1301",
            "pmid": "22894964",
            "pub_year": 2012,
            "title": "Modeling the economic value of a Chagas' disease therapeutic vaccine",
            "volume": "8"
        },
        "bib0350": {
            "authors": [
                {
                    "first": "Samuel",
                    "initial": "S.",
                    "last": "Goldenberg"
                },
                {
                    "first": "Andrea Rodrigues",
                    "initial": "A.R.",
                    "last": "\u00c1vila"
                }
            ],
            "doi": "10.1016/B978-0-12-385863-4.00013-7",
            "firstpage": "285",
            "issn": "0065308X",
            "lastpage": "305",
            "pub_year": 2011,
            "title": "Aspects of Trypanosoma cruzi Stage Differentiation",
            "volume": "75"
        },
        "bib0355": {
            "authors": [
                {
                    "first": "Anis",
                    "initial": "A.",
                    "last": "Rassi"
                },
                {
                    "first": "Anis",
                    "initial": "A.",
                    "last": "Rassi"
                },
                {
                    "first": "Jos\u00e9 Antonio",
                    "initial": "J.A.",
                    "last": "Marin-Neto"
                }
            ],
            "doi": "10.1016/S0140-6736(10)60061-X",
            "firstpage": "1388",
            "issn": "01406736",
            "lastpage": "1402",
            "pmid": "20399979",
            "pub_year": 2010,
            "title": "Chagas disease",
            "volume": "375"
        },
        "bib0360": {
            "authors": [
                {
                    "first": "Fabiana S.",
                    "initial": "F.S.",
                    "last": "Machado"
                },
                {
                    "first": "Walderez O.",
                    "initial": "W.O.",
                    "last": "Dutra"
                },
                {
                    "first": "Lisia",
                    "initial": "L.",
                    "last": "Esper"
                },
                {
                    "first": "Kenneth J.",
                    "initial": "K.J.",
                    "last": "Gollob"
                },
                {
                    "first": "Mauro M.",
                    "initial": "M.M.",
                    "last": "Teixeira"
                },
                {
                    "first": "Stephen M.",
                    "initial": "S.M.",
                    "last": "Factor"
                },
                {
                    "first": "Louis M.",
                    "initial": "L.M.",
                    "last": "Weiss"
                },
                {
                    "first": "Fnu",
                    "initial": "F.",
                    "last": "Nagajyothi"
                },
                {
                    "first": "Herbert B.",
                    "initial": "H.B.",
                    "last": "Tanowitz"
                },
                {
                    "first": "Nisha J.",
                    "initial": "N.J.",
                    "last": "Garg"
                }
            ],
            "doi": "10.1007/s00281-012-0351-7",
            "firstpage": "753",
            "issn": "18632297",
            "lastpage": "770",
            "pmid": "23076807",
            "pub_year": 2012,
            "title": "Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease",
            "volume": "34"
        },
        "bib0365": {
            "authors": [
                {
                    "first": "Werner",
                    "initial": "W.",
                    "last": "Apt"
                }
            ],
            "doi": "10.2147/DDDT.S8338",
            "firstpage": "243",
            "issn": "11778881",
            "lastpage": "253",
            "pmid": "20957215",
            "pub_year": 2010,
            "title": "Current and developing therapeutic agents in the treatment of Chagas disease",
            "volume": "4"
        },
        "bib0370": {
            "authors": [
                {
                    "first": "Peter J.",
                    "initial": "P.J.",
                    "last": "Hotez"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Dumonteil"
                },
                {
                    "first": "Miguel",
                    "initial": "M.",
                    "last": "Betancourt Cravioto"
                },
                {
                    "first": "Maria Elena",
                    "initial": "M.E.",
                    "last": "Bottazzi"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Tapia-Conyer"
                },
                {
                    "first": "Sheba",
                    "initial": "S.",
                    "last": "Meymandi"
                },
                {
                    "first": "Unni",
                    "initial": "U.",
                    "last": "Karunakara"
                },
                {
                    "first": "Isabela",
                    "initial": "I.",
                    "last": "Ribeiro"
                },
                {
                    "first": "Rachel M.",
                    "initial": "R.M.",
                    "last": "Cohen"
                },
                {
                    "first": "Bernard",
                    "initial": "B.",
                    "last": "Pecoul"
                }
            ],
            "doi": "10.1371/journal.pntd.0002300",
            "issn": "19352727",
            "pmid": "24205411",
            "pub_year": 2013,
            "title": "An Unfolding Tragedy of Chagas Disease in North America",
            "volume": "7"
        },
        "bib0375": {
            "authors": [
                {
                    "first": "C. A.",
                    "initial": "C.A.",
                    "last": "Morillo"
                },
                {
                    "first": "J. A.",
                    "initial": "J.A.",
                    "last": "Marin-Neto"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Avezum"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Sosa-Estani"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Rassi"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Rosas"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Villena"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Quiroz"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Bonilla"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Britto"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Guhl"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Velazquez"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Bonilla"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Meeks"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Rao-Melacini"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Pogue"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Mattos"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Lazdins"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Rassi"
                },
                {
                    "first": "S. J.",
                    "initial": "S.J.",
                    "last": "Connolly"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Yusuf"
                }
            ],
            "doi": "10.1056/NEJMoa1507574",
            "firstpage": "1295",
            "issn": "00284793",
            "lastpage": "1306",
            "pmid": "26323937",
            "pub_year": 2015,
            "title": "Randomized trial of benznidazole for chronic chagas' cardiomyopathy",
            "volume": "373"
        },
        "bib0380": {
            "authors": [
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Dumonteil"
                },
                {
                    "first": "Maria Elena",
                    "initial": "M.E.",
                    "last": "Bottazzi"
                },
                {
                    "first": "Bin",
                    "initial": "B.",
                    "last": "Zhan"
                },
                {
                    "first": "Michael J.",
                    "initial": "M.J.",
                    "last": "Heffernan"
                },
                {
                    "first": "Kathryn",
                    "initial": "K.",
                    "last": "Jones"
                },
                {
                    "first": "Jesus G.",
                    "initial": "J.G.",
                    "last": "Valenzuela"
                },
                {
                    "first": "Shaden",
                    "initial": "S.",
                    "last": "Kamhawi"
                },
                {
                    "first": "Jaime",
                    "initial": "J.",
                    "last": "Ortega"
                },
                {
                    "first": "Samuel Ponce",
                    "initial": "S.P.",
                    "last": "De Leon Rosales"
                },
                {
                    "first": "Bruce Y.",
                    "initial": "B.Y.",
                    "last": "Lee"
                },
                {
                    "first": "Kristina M.",
                    "initial": "K.M.",
                    "last": "Bacon"
                },
                {
                    "first": "Bernhard",
                    "initial": "B.",
                    "last": "Fleischer"
                },
                {
                    "first": "B. T.",
                    "initial": "B.T.",
                    "last": "Slingsby"
                },
                {
                    "first": "Miguel Betancourt",
                    "initial": "M.B.",
                    "last": "Cravioto"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Tapia-Conyer"
                },
                {
                    "first": "Peter J.",
                    "initial": "P.J.",
                    "last": "Hotez"
                }
            ],
            "doi": "10.1586/erv.12.85",
            "firstpage": "1043",
            "issn": "14760584",
            "lastpage": "1055",
            "pmid": "23151163",
            "pub_year": 2012,
            "title": "Accelerating the development of a therapeutic vaccine for human Chagas disease: Rationale and prospects",
            "volume": "11"
        },
        "bib0385": {
            "authors": [
                {
                    "first": "Israel",
                    "initial": "I.",
                    "last": "Quijano-Hernandez"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Dumonteil"
                }
            ],
            "doi": "10.4161/hv.7.11.17016",
            "firstpage": "1184",
            "issn": "15548600",
            "lastpage": "1191",
            "pub_year": 2011,
            "title": "Advances and challenges toward a vaccine against Chagas disease",
            "volume": "7"
        },
        "bib0390": {
            "authors": [
                {
                    "first": "Coreen M.",
                    "initial": "C.M.",
                    "last": "Beaumier"
                },
                {
                    "first": "Portia M.",
                    "initial": "P.M.",
                    "last": "Gillespie"
                },
                {
                    "first": "Peter J.",
                    "initial": "P.J.",
                    "last": "Hotez"
                },
                {
                    "first": "Maria Elena",
                    "initial": "M.E.",
                    "last": "Bottazzi"
                }
            ],
            "doi": "10.1016/j.trsl.2013.03.006",
            "firstpage": "144",
            "issn": "19315244",
            "lastpage": "155",
            "pub_year": 2013,
            "title": "New vaccines for neglected parasitic diseases and dengue",
            "volume": "162"
        },
        "bib0395": {
            "authors": [
                {
                    "first": "Bruce Y.",
                    "initial": "B.Y.",
                    "last": "Lee"
                },
                {
                    "first": "Kristina M.",
                    "initial": "K.M.",
                    "last": "Bacon"
                },
                {
                    "first": "Diana L.",
                    "initial": "D.L.",
                    "last": "Connor"
                },
                {
                    "first": "Alyssa M.",
                    "initial": "A.M.",
                    "last": "Willig"
                },
                {
                    "first": "Rachel R.",
                    "initial": "R.R.",
                    "last": "Bailey"
                }
            ],
            "doi": "10.1371/journal.pntd.0000916",
            "firstpage": "1",
            "lastpage": "8",
            "pmid": "21179503",
            "pub_year": 2010,
            "title": "The potential economic value of a Trypanosoma cruzi (chagas disease) vaccine in Latin America",
            "volume": "4"
        },
        "bib0400": {
            "authors": [
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Chatelain"
                },
                {
                    "first": "Nandini",
                    "initial": "N.",
                    "last": "Konar"
                }
            ],
            "doi": "10.2147/DDDT.S90208",
            "firstpage": "4807",
            "issn": "11778881",
            "lastpage": "4823",
            "pmid": "26316715",
            "pub_year": 2015,
            "title": "Translational challenges of animal models in chagas disease drug development: A review",
            "volume": "9"
        },
        "bib0405": {
            "authors": [
                {
                    "first": "Peter J.",
                    "initial": "P.J.",
                    "last": "Hotez"
                },
                {
                    "first": "Miriam",
                    "initial": "M.",
                    "last": "Alvarado"
                },
                {
                    "first": "Mar\u00eda Gloria",
                    "initial": "M.G.",
                    "last": "Bas\u00e1\u00f1ez"
                },
                {
                    "first": "Ian",
                    "initial": "I.",
                    "last": "Bolliger"
                },
                {
                    "first": "Rupert",
                    "initial": "R.",
                    "last": "Bourne"
                },
                {
                    "first": "Michel",
                    "initial": "M.",
                    "last": "Boussinesq"
                },
                {
                    "first": "Simon J.",
                    "initial": "S.J.",
                    "last": "Brooker"
                },
                {
                    "first": "Ami Shah",
                    "initial": "A.S.",
                    "last": "Brown"
                },
                {
                    "first": "Geoffrey",
                    "initial": "G.",
                    "last": "Buckle"
                },
                {
                    "first": "Christine M.",
                    "initial": "C.M.",
                    "last": "Budke"
                },
                {
                    "first": "H\u00e9l\u00e8ne",
                    "initial": "H.",
                    "last": "Carabin"
                },
                {
                    "first": "Luc E.",
                    "initial": "L.E.",
                    "last": "Coffeng"
                },
                {
                    "first": "Eric M.",
                    "initial": "E.M.",
                    "last": "F\u00e8vre"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "F\u00fcrst"
                },
                {
                    "first": "Yara A.",
                    "initial": "Y.A.",
                    "last": "Halasa"
                },
                {
                    "first": "Rashmi",
                    "initial": "R.",
                    "last": "Jasrasaria"
                },
                {
                    "first": "Nicole E.",
                    "initial": "N.E.",
                    "last": "Johns"
                },
                {
                    "first": "Jennifer",
                    "initial": "J.",
                    "last": "Keiser"
                },
                {
                    "first": "Charles H.",
                    "initial": "C.H.",
                    "last": "King"
                },
                {
                    "first": "Rafael",
                    "initial": "R.",
                    "last": "Lozano"
                },
                {
                    "first": "Michele E.",
                    "initial": "M.E.",
                    "last": "Murdoch"
                },
                {
                    "first": "Simon",
                    "initial": "S.",
                    "last": "O'Hanlon"
                },
                {
                    "first": "S\u00e9bastien D.S.",
                    "initial": "S.D.S.",
                    "last": "Pion"
                },
                {
                    "first": "Rachel L.",
                    "initial": "R.L.",
                    "last": "Pullan"
                },
                {
                    "first": "Kapa D.",
                    "initial": "K.D.",
                    "last": "Ramaiah"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Roberts"
                },
                {
                    "first": "Donald S.",
                    "initial": "D.S.",
                    "last": "Shepard"
                },
                {
                    "first": "Jennifer L.",
                    "initial": "J.L.",
                    "last": "Smith"
                },
                {
                    "first": "Wilma A.",
                    "initial": "W.A.",
                    "last": "Stolk"
                },
                {
                    "first": "Eduardo A.",
                    "initial": "E.A.",
                    "last": "Undurraga"
                },
                {
                    "first": "J\u00fcrg",
                    "initial": "J.",
                    "last": "Utzinger"
                },
                {
                    "first": "Mengru",
                    "initial": "M.",
                    "last": "Wang"
                },
                {
                    "first": "Christopher J.L.",
                    "initial": "C.J.L.",
                    "last": "Murray"
                },
                {
                    "first": "Mohsen",
                    "initial": "M.",
                    "last": "Naghavi"
                }
            ],
            "doi": "10.1371/journal.pntd.0002865",
            "issn": "19352727",
            "pub_year": 2014,
            "title": "The Global Burden of Disease Study 2010: Interpretation and Implications for the Neglected Tropical Diseases",
            "volume": "8"
        },
        "bib0410": {
            "authors": [
                {
                    "first": "Faustino R.",
                    "initial": "F.R.",
                    "last": "P\u00e9rez-L\u00f3pez"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Chedraui"
                }
            ],
            "doi": "10.1007/s00404-010-1553-7",
            "firstpage": "595",
            "issn": "09320067",
            "lastpage": "599",
            "pmid": "20559648",
            "pub_year": 2010,
            "title": "Chagas disease in pregnancy: A non-endemic problem in a globalized world",
            "volume": "282"
        },
        "bib0415": {
            "authors": [
                {
                    "first": "Miguel",
                    "initial": "M.",
                    "last": "Zabalgoitia"
                },
                {
                    "first": "Jaime",
                    "initial": "J.",
                    "last": "Ventura"
                },
                {
                    "first": "Lori",
                    "initial": "L.",
                    "last": "Anderson"
                },
                {
                    "first": "K. D.",
                    "initial": "K.D.",
                    "last": "Carey"
                },
                {
                    "first": "Jeff T.",
                    "initial": "J.T.",
                    "last": "Williams"
                },
                {
                    "first": "John L.",
                    "initial": "J.L.",
                    "last": "Vandeberg"
                }
            ],
            "doi": "10.4269/ajtmh.2003.68.248",
            "firstpage": "248",
            "issn": "00029637",
            "lastpage": "252",
            "pmid": "12641420",
            "pub_year": 2003,
            "title": "Morphologic and functional characterization of chagasic heart disease in non-human primates",
            "volume": "68"
        },
        "bib0420": {
            "authors": [
                {
                    "first": "Joseph D.",
                    "initial": "J.D.",
                    "last": "Planer"
                },
                {
                    "first": "Matthew A.",
                    "initial": "M.A.",
                    "last": "Hulverson"
                },
                {
                    "first": "Jennifer A.",
                    "initial": "J.A.",
                    "last": "Arif"
                },
                {
                    "first": "Ranae M.",
                    "initial": "R.M.",
                    "last": "Ranade"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Don"
                },
                {
                    "first": "Frederick S.",
                    "initial": "F.S.",
                    "last": "Buckner"
                }
            ],
            "doi": "10.1371/journal.pntd.0002977",
            "issn": "19352727",
            "pmid": "25033456",
            "pub_year": 2014,
            "title": "Synergy Testing of FDA-Approved Drugs Identifies Potent Drug Combinations against Trypanosoma cruzi",
            "volume": "8"
        },
        "bib0425": {
            "authors": [
                {
                    "first": "Anal\u00eda I.",
                    "initial": "A.I.",
                    "last": "Porr\u00e1s"
                },
                {
                    "first": "Zaida E.",
                    "initial": "Z.E.",
                    "last": "Yadon"
                },
                {
                    "first": "Jaime",
                    "initial": "J.",
                    "last": "Altcheh"
                },
                {
                    "first": "Constan\u00e7a",
                    "initial": "C.",
                    "last": "Britto"
                },
                {
                    "first": "Gabriela C.",
                    "initial": "G.C.",
                    "last": "Chaves"
                },
                {
                    "first": "Laurence",
                    "initial": "L.",
                    "last": "Flevaud"
                },
                {
                    "first": "Olindo Assis",
                    "initial": "O.A.",
                    "last": "Martins-Filho"
                },
                {
                    "first": "Isabela",
                    "initial": "I.",
                    "last": "Ribeiro"
                },
                {
                    "first": "Alejandro G.",
                    "initial": "A.G.",
                    "last": "Schijman"
                },
                {
                    "first": "Maria Aparecida",
                    "initial": "M.A.",
                    "last": "Shikanai-Yasuda"
                },
                {
                    "first": "Sergio",
                    "initial": "S.",
                    "last": "Sosa-Estani"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Stobbaerts"
                },
                {
                    "first": "Fabio",
                    "initial": "F.",
                    "last": "Zicker"
                }
            ],
            "doi": "10.1371/journal.pntd.0003697",
            "issn": "19352727",
            "pub_year": 2015,
            "title": "Target product profile (TPP) for chagas disease point-of-care diagnosis and assessment of response to treatment",
            "volume": "9"
        },
        "bib0430": {
            "authors": [
                {
                    "first": "Olivia",
                    "initial": "O.",
                    "last": "Rodr\u00edguez-Morales"
                },
                {
                    "first": "V\u00edctor",
                    "initial": "V.",
                    "last": "Monte\u00f3n-Padilla"
                },
                {
                    "first": "Silvia C.",
                    "initial": "S.C.",
                    "last": "Carrillo-S\u00e1nchez"
                },
                {
                    "first": "Martha",
                    "initial": "M.",
                    "last": "Rios-Castro"
                },
                {
                    "first": "Mariana",
                    "initial": "M.",
                    "last": "Mart\u00ednez-Cruz"
                },
                {
                    "first": "Alejandro",
                    "initial": "A.",
                    "last": "Carabarin-Lima"
                },
                {
                    "first": "Minerva",
                    "initial": "M.",
                    "last": "Arce-Fonseca"
                }
            ],
            "doi": "10.1155/2015/489758",
            "issn": "23148861",
            "pmid": "26090490",
            "pub_year": 2015,
            "title": "Experimental Vaccines against Chagas Disease: A Journey through History",
            "volume": "2015"
        },
        "bib0435": null
    },
    "body_text": [
        {
            "endOffset": 12963,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "secId": "sec0020",
            "sentence": "The efficacy of both drugs for many patients with chronic Chagas disease diminishes the longer a person has been infected.",
            "startOffset": 12841,
            "title": "Current approaches to treatment"
        },
        {
            "endOffset": 19257,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "refoffsets": {
                "bib0345": {
                    "endOffset": 19256,
                    "startOffset": 19252
                }
            },
            "secId": "sec0035",
            "sentence": "A therapeutic vaccine though, as a standalone therapy or used together with benznidazole and nifurtimox in a vaccine-linked chemotherapy approach, is likely the currently desired (and probably most feasible) strategy for vaccine development with the potential to reduce the dose and/or the treatment duration, therefore ultimately reducing the toxicity of current and even emerging chemotherapeutics [15].",
            "startOffset": 18852,
            "title": "General approaches to vaccine development for this disease for low- and middle-income country markets"
        },
        {
            "endOffset": 8963,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "refoffsets": {
                "bib0330": {
                    "endOffset": 8962,
                    "startOffset": 8958
                }
            },
            "secId": "sec0010",
            "sentence": "Despite its global importance in the most affected Western Hemispheric countries, it is estimated that only a small percentage of Chagas disease patients are diagnosed and receive access to essential medicines and other healthcare [12].",
            "startOffset": 8727,
            "title": "Global disease and economic burden"
        },
        {
            "endOffset": 14118,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0030",
            "sentence": "Currently there are at least two major potential Target Product Profiles (TPPs) for a Chagas disease vaccine (Box 1).",
            "startOffset": 14001,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 18624,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0035",
            "sentence": "As alluded to above, several recent preclinical studies have used recombinant proteins, recombinant viral (adenovirus) vectors, DNA platforms, and heterologous prime-boost vaccination regimens and elicited protection against infection and increased survival in murine models (Table 1).",
            "startOffset": 18339,
            "title": "General approaches to vaccine development for this disease for low- and middle-income country markets"
        },
        {
            "endOffset": 16090,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0030",
            "sentence": "However, there is general agreement on the need for new therapeutic anti-trypanosomal products that go beyond the currently available drugs, benznidazole and nifurtimox.",
            "startOffset": 15921,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 15624,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "refoffsets": {
                "bib0340": {
                    "endOffset": 15623,
                    "startOffset": 15613
                },
                "bib0345": {
                    "endOffset": 15623,
                    "startOffset": 15613
                },
                "bib0395": {
                    "endOffset": 15623,
                    "startOffset": 15613
                }
            },
            "secId": "sec0030",
            "sentence": "Cost-effectiveness studies have been conducted on both the preventive and therapeutic vaccine TPPs [14,15,25].",
            "startOffset": 15514,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 10499,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "refoffsets": {
                "bib0350": {
                    "endOffset": 10498,
                    "startOffset": 10494
                }
            },
            "secId": "sec0015",
            "sentence": "The cycle is completed when triatomines take up trypomastigotes during subsequent feedings, and the parasite develops into the epimastigote form in the midgut, which multiplies by binary fission, and back into trypomastigotes in the hindgut [16].",
            "startOffset": 10253,
            "title": "Natural history and clinical disease"
        },
        {
            "endOffset": 8727,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "refoffsets": {
                "bib0320": {
                    "endOffset": 8726,
                    "startOffset": 8719
                },
                "bib0325": {
                    "endOffset": 8726,
                    "startOffset": 8719
                }
            },
            "secId": "sec0010",
            "sentence": "Also, of particular concern are the large numbers of cases in the southern United States, especially Texas where emerging evidence indicates a significant level of autochthonous transmission [10,11].",
            "startOffset": 8528,
            "title": "Global disease and economic burden"
        },
        {
            "endOffset": 12840,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "secId": "sec0020",
            "sentence": "However, very few patients are diagnosed in the acute stages because these stages are often silent, or because the patients do not have access to proper diagnosis and treatment.",
            "startOffset": 12663,
            "title": "Current approaches to treatment"
        },
        {
            "endOffset": 17483,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "refoffsets": {
                "bib0380": {
                    "endOffset": 17482,
                    "startOffset": 17475
                },
                "bib0385": {
                    "endOffset": 17482,
                    "startOffset": 17475
                }
            },
            "secId": "sec0030",
            "sentence": "It has further been observed that the efficacy of T. cruzi vaccines in pre-clinical models will be greatly influenced by the vaccine formulations used and their resulting immune response [22,23].",
            "startOffset": 17288,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 16646,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0030",
            "sentence": "In addition, initial safety concerns over exacerbating pre-existing cardiac lesions through activation of an autoimmune reaction, based on earlier assertions that there is an important autoimmune component to Chagas disease pathogenesis.",
            "startOffset": 16409,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 15038,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "refoffsets": {
                "bib0345": {
                    "endOffset": 15037,
                    "startOffset": 15033
                }
            },
            "secId": "sec0030",
            "sentence": "A therapeutic vaccine administered alone or in combination with chemotherapy would be used to prevent or delay the onset of Chagasic cardiomyopathy in patients who have seroconverted to T. cruzi infection and are at the indeterminate or early determinate stage [15].",
            "startOffset": 14772,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 14771,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0030",
            "sentence": "A preventative vaccine if used in highly endemic areas could potentially prevent acute infection (especially in a hyperendemic setting found in some parts of Latin America) but is unlikely to interrupt disease transmission because of the large number of animal reservoirs and zoonotic hosts, typically found in these endemic areas.",
            "startOffset": 14440,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 19374,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0035",
            "sentence": "It is estimated that an effective vaccine could have a significant impact on the prevention of cardiac complications.",
            "startOffset": 19257,
            "title": "General approaches to vaccine development for this disease for low- and middle-income country markets"
        },
        {
            "endOffset": 7436,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "refoffsets": {
                "bib0280": {
                    "endOffset": 7435,
                    "startOffset": 7430
                },
                "bib0285": {
                    "endOffset": 7435,
                    "startOffset": 7430
                },
                "bib0290": {
                    "endOffset": 7435,
                    "startOffset": 7430
                }
            },
            "secId": "sec0010",
            "sentence": "An estimated 7\u20138 million people are infected worldwide with almost all of the cases occurring in the Americas, predominantly in the poorest countries in the region [2\u20134].",
            "startOffset": 7266,
            "title": "Global disease and economic burden"
        },
        {
            "endOffset": 11360,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "secId": "sec0015",
            "sentence": "Cardiac complications in particular, occurring in 20\u201330% of patients, cause the most severe morbidity and mortality and are characterized by arrhythmias, aneurysms, and heart failure.",
            "startOffset": 11177,
            "title": "Natural history and clinical disease"
        },
        {
            "endOffset": 15514,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0030",
            "sentence": "Therapeutic Chagas disease vaccine linked to anti-parasitic chemotherapy (\u2018vaccine linked chemotherapy\u2019)",
            "startOffset": 15410,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 7969,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "refoffsets": {
                "bib0290": {
                    "endOffset": 7968,
                    "startOffset": 7961
                },
                "bib0295": {
                    "endOffset": 7968,
                    "startOffset": 7961
                },
                "bib0310": {
                    "endOffset": 7968,
                    "startOffset": 7961
                }
            },
            "secId": "sec0010",
            "sentence": "In total, combining years of life lost and YLDs, Chagas disease causes approximately 0.6 million disability adjusted life years (DALYs), a measure integrating a disease's morbidity and mortality [4,5,8].",
            "startOffset": 7766,
            "title": "Global disease and economic burden"
        },
        {
            "endOffset": 20803,
            "parents": [],
            "refoffsets": {
                "bib0415": {
                    "endOffset": 20802,
                    "startOffset": 20798
                }
            },
            "secId": "sec0040",
            "sentence": "It has been noted that a significant percentage of NHPs living outdoors in primate centers in Chagas endemic areas of the Western Hemisphere are actually infected with T. cruzi [29].",
            "startOffset": 20621,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 9688,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "refoffsets": {
                "bib0340": {
                    "endOffset": 9687,
                    "startOffset": 9680
                },
                "bib0345": {
                    "endOffset": 9687,
                    "startOffset": 9680
                }
            },
            "secId": "sec0010",
            "sentence": "In addition to its global health impact, Chagas disease has been demonstrated to be one of the largest causes of why Latin America's poorest population, the \u201cbottom 100 million\u201d, remain impoverished ($7 billion annual losses to the economy) [14,15].",
            "startOffset": 9439,
            "title": "Global disease and economic burden"
        },
        {
            "endOffset": 16200,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0030",
            "sentence": "Both scientific and socioeconomic challenges have hindered the development of vaccines against Chagas disease.",
            "startOffset": 16090,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 10795,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "secId": "sec0015",
            "sentence": "Exposure to the T. cruzi parasite results in the development of an acute infection, which is often asymptomatic and lasting for 4\u20138 weeks, but can also be characterized by a rather telling localized swelling at the site of infection (Chagoma), or a special form of conjunctivitis (Roma\u00f1a's sign).",
            "startOffset": 10499,
            "title": "Natural history and clinical disease"
        },
        {
            "endOffset": 12421,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "refoffsets": {
                "bib0305": {
                    "endOffset": 12302,
                    "startOffset": 12299
                },
                "bib0365": {
                    "endOffset": 12420,
                    "startOffset": 12413
                },
                "bib0370": {
                    "endOffset": 12420,
                    "startOffset": 12413
                }
            },
            "secId": "sec0015",
            "sentence": "Hundreds of thousands of pregnant women in the Americas now live with Chagas disease, while maternal-to-child transmission of T. cruzi leading to congenital Chagas disease has resulted in 8668 documented neonates infected in Latin America (in 2010), with Mexico having the largest number of cases of congenital Chagas disease [7], though these estimates do not likely represent the true number of cases due to poor detection of the disease [19,20].",
            "startOffset": 11973,
            "title": "Natural history and clinical disease"
        },
        {
            "endOffset": 19996,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "refoffsets": {
                "bib0395": {
                    "endOffset": 19995,
                    "startOffset": 19988
                },
                "bib0410": {
                    "endOffset": 19995,
                    "startOffset": 19988
                }
            },
            "secId": "sec0035",
            "sentence": "In addition, it is expected that a vaccine could serve to reduce child mortality and improve maternal health and pregnancy outcome in Latin American countries and could simultaneously reduce cost of treatment for this disease, while increasing efficacy in treating disease symptoms [25,28].",
            "startOffset": 19706,
            "title": "General approaches to vaccine development for this disease for low- and middle-income country markets"
        },
        {
            "endOffset": 17791,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0030",
            "sentence": "The advantages of rodent models, most commonly mice, are lower cost for housing and handling, and a shorter lifespan resulting in quicker results.",
            "startOffset": 17645,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 21198,
            "parents": [],
            "refoffsets": {
                "bib0425": {
                    "endOffset": 21197,
                    "startOffset": 21193
                }
            },
            "secId": "sec0040",
            "sentence": "In addition, efforts are underway at PAHO and the WHO to assess the response to anti-parasitic treatment in the chronic phase of the disease, which we expect to be equally beneficial for the evaluation of vaccine efficacy in humans [31].",
            "startOffset": 20961,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 21947,
            "parents": [],
            "secId": "sec0045",
            "sentence": "Many of these candidates are DNA vaccines undergoing testing in mice.",
            "startOffset": 21878,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 13593,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "secId": "sec0020",
            "sentence": "Furthermore, the drugs are contraindicated in pregnancy and for those with kidney or liver failure.",
            "startOffset": 13494,
            "title": "Current approaches to treatment"
        },
        {
            "endOffset": 13227,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "refoffsets": {
                "bib0375": {
                    "endOffset": 13226,
                    "startOffset": 13222
                }
            },
            "secId": "sec0020",
            "sentence": "In fact, a recent randomized trial of patients showing evidence of Chagasic cardiomyopathy failed to show any benefit for patients treated with benznidazole versus an untreated control cohort when it came to the progression of cardiac clinical deterioration [21].",
            "startOffset": 12964,
            "title": "Current approaches to treatment"
        },
        {
            "endOffset": 16980,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "refoffsets": {
                "bib0360": {
                    "endOffset": 16979,
                    "startOffset": 16969
                },
                "bib0380": {
                    "endOffset": 16979,
                    "startOffset": 16969
                },
                "bib0385": {
                    "endOffset": 16979,
                    "startOffset": 16969
                }
            },
            "secId": "sec0030",
            "sentence": "However, most investigators currently believe that it is parasite persistence that is associated with disease progression, and that a strong CD8+ T cell immune response will need to be induced, encompassing either interferon-gamma or cytotoxic activity, or both, in order to control T. cruzi infection through vaccination [18,22,23].",
            "startOffset": 16647,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 21491,
            "parents": [],
            "secId": "sec0045",
            "sentence": "These approaches range from immunization with attenuated parasites of non-pathogenic Trypanosoma strains, to DNA vaccines and recombinant protein vaccines.",
            "startOffset": 21336,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 15335,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0030",
            "sentence": "Preventive Chagas disease vaccine",
            "startOffset": 15302,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 15920,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0030",
            "sentence": "There is as yet no consensus among the community of Chagas disease researchers on the urgency for developing a prophylactic vaccine.",
            "startOffset": 15788,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 11972,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "secId": "sec0015",
            "sentence": "While most of Chagas disease occurring in the Americas is transmitted by triatomines, there is now also evidence for increasing maternal-to-child transmission of the disease, resulting in congenital Chagas disease.",
            "startOffset": 11758,
            "title": "Natural history and clinical disease"
        },
        {
            "endOffset": 13493,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "secId": "sec0020",
            "sentence": "Therefore, the benefits of medication in preventing or delaying the development of Chagas disease has to be weighed against the long duration of treatment (up to two months) and relatively high rates of adverse reactions that occur in up to 40% of treated patients.",
            "startOffset": 13228,
            "title": "Current approaches to treatment"
        },
        {
            "endOffset": 21335,
            "parents": [],
            "secId": "sec0045",
            "sentence": "A variety of different approaches to the development of Chagas vaccines is underway as shown in Table 1.",
            "startOffset": 21231,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 17911,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0030",
            "sentence": "However, it is often difficult for the murine systems to completely reflect the pathology seen in human Chagas disease.",
            "startOffset": 17792,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 12662,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "secId": "sec0020",
            "sentence": "Current treatment is dependent on two drugs, benznidazole or nifurtimox, both of which are highly effective, provided therapy is initiated at the onset of infection and during the acute phase of the disease.",
            "startOffset": 12455,
            "title": "Current approaches to treatment"
        },
        {
            "endOffset": 17287,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0030",
            "sentence": "Evidence from the testing of a wide range of vaccine formulations over the years that range from whole parasites, to purified or recombinant proteins, viral vectors and DNA vaccines have provided preliminary pre-clinical proof-of-concept for vaccination as a preventive and potentially therapeutic strategy.",
            "startOffset": 16980,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 21707,
            "parents": [],
            "secId": "sec0045",
            "sentence": "Currently, all candidates are still in the preclinical phase of testing and not yet in clinical trials.",
            "startOffset": 21604,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 18851,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0035",
            "sentence": "The success of either a preventative or therapeutic vaccine would depend on its ability to induce a TH1-mediated immune response suggesting that the same antigens and formulations would be efficacious for both types of vaccine.",
            "startOffset": 18624,
            "title": "General approaches to vaccine development for this disease for low- and middle-income country markets"
        },
        {
            "endOffset": 14439,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "refoffsets": {
                "bib0385": {
                    "endOffset": 14438,
                    "startOffset": 14431
                },
                "bib0390": {
                    "endOffset": 14438,
                    "startOffset": 14431
                }
            },
            "secId": "sec0030",
            "sentence": "It is widely noted that a therapeutic or preventative T. cruzi vaccine would be highly beneficial in controlling Chagas disease [23,24].",
            "startOffset": 14303,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 18082,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0030",
            "sentence": "Canine and NHP models often more successfully mimic the human responses and pathologies observed, but, with their longer lifespan, experimental results are often delayed.",
            "startOffset": 17912,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 24027,
            "parents": [],
            "secId": "sec0055",
            "sentence": "Several of the authors are investigators and patent holders on vaccines against hookworm and other neglected tropical diseases and are supported in part by grants to develop these vaccines.",
            "startOffset": 23838,
            "title": "Conflicts of interest"
        },
        {
            "endOffset": 7229,
            "parents": [],
            "refoffsets": {
                "bib0275": {
                    "endOffset": 7228,
                    "startOffset": 7225
                }
            },
            "secId": "sec0005",
            "sentence": "Chagas disease (American trypanosomiasis caused by Trypanosoma cruzi) is a vector-borne parasitic infection transmitted by triatomines (kissing bugs), today considered one of the most important neglected tropical diseases globally (NTDs) [1].",
            "startOffset": 6987,
            "title": "About the disease and pathogen"
        },
        {
            "endOffset": 14302,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0030",
            "sentence": "The first is a prophylactic vaccine that would prevent acute infection and the second is a therapeutic vaccine for patients that have seroconverted and are at the indeterminate stage.",
            "startOffset": 14119,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 9072,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "secId": "sec0010",
            "sentence": "Patients with Chagas disease typically live in extreme poverty and represent a highly vulnerable population.",
            "startOffset": 8964,
            "title": "Global disease and economic burden"
        },
        {
            "endOffset": 11176,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "secId": "sec0015",
            "sentence": "Virtually all of these acutely infected individuals seroconvert to T. cruzi, but approximately 60\u201370% of these individuals do not progress to clinically apparent disease (indeterminate status), while the remaining 30\u201340% move on to develop the chronic form of the disease (determinate status), concomitant with the appearance of cardiac and/or gastrointestinal signs and symptoms.",
            "startOffset": 10796,
            "title": "Natural history and clinical disease"
        },
        {
            "endOffset": 13924,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "secId": "sec0020",
            "sentence": "Given this current situation, there is an urgent need for a new treatment strategy is crucially needed for chronic Chagas disease, including a safe and effective vaccine.",
            "startOffset": 13754,
            "title": "Current approaches to treatment"
        },
        {
            "endOffset": 10252,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "secId": "sec0015",
            "sentence": "Within its mammalian host the parasite then transforms into its intracellular amastigote form, and concomitant with the eventual rupture of these host cells, blood-form trypomastigotes are released.",
            "startOffset": 10054,
            "title": "Natural history and clinical disease"
        },
        {
            "endOffset": 11758,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "refoffsets": {
                "bib0360": {
                    "endOffset": 11757,
                    "startOffset": 11753
                }
            },
            "secId": "sec0015",
            "sentence": "Pathological findings in chronic Chagasic gastrointestinal disease include dilatation and muscular hypertrophy of the colon or the oesophagus, as well as injury to the parasympathetic nervous system [18].",
            "startOffset": 11554,
            "title": "Natural history and clinical disease"
        },
        {
            "endOffset": 23817,
            "parents": [],
            "secId": "sec0050",
            "sentence": "Because Chagas disease is endemic to both wealthy Latin American nations and the United States, and there is evidence of globalization of Chagas disease to Europe, Australia, Japan, and elsewhere, this could potentially incentivise investment from the pharmaceutical industry upon preclinical and clinical proof-of-concept trials.",
            "startOffset": 23487,
            "title": "Likelihood for financing"
        },
        {
            "endOffset": 7765,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "refoffsets": {
                "bib0295": {
                    "endOffset": 7764,
                    "startOffset": 7759
                },
                "bib0305": {
                    "endOffset": 7764,
                    "startOffset": 7759
                }
            },
            "secId": "sec0010",
            "sentence": "Further estimates are that Chagas disease is responsible for 10,600 deaths per year in addition to 97,500 years lived with disability (YLDs) [5,7].",
            "startOffset": 7618,
            "title": "Global disease and economic burden"
        },
        {
            "endOffset": 18235,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "refoffsets": {
                "bib0400": {
                    "endOffset": 18234,
                    "startOffset": 18230
                }
            },
            "secId": "sec0030",
            "sentence": "In addition, ethical concerns that surround their use and the significant increase in cost involved must be considered when planning these studies [26].",
            "startOffset": 18083,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 15266,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0030",
            "sentence": "Some investigators refer to this combination as \u201cvaccine-linked chemotherapy\u201d.",
            "startOffset": 15188,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 15302,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0030",
            "sentence": "TPPs for Chagas disease vaccine",
            "startOffset": 15271,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 7617,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "refoffsets": {
                "bib0295": {
                    "endOffset": 7616,
                    "startOffset": 7611
                },
                "bib0300": {
                    "endOffset": 7616,
                    "startOffset": 7611
                }
            },
            "secId": "sec0010",
            "sentence": "However, revised estimates taking into consideration underreporting and poor diagnosis suggest that the number of total worldwide Chagas cases is much closer to 9\u201310 million [5,6].",
            "startOffset": 7437,
            "title": "Global disease and economic burden"
        },
        {
            "endOffset": 20620,
            "parents": [],
            "secId": "sec0040",
            "sentence": "The critical path for clinical development could likely involve a first test of safety of the vaccine in an NHP model prior to first-in-human trials.",
            "startOffset": 20471,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 8527,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "refoffsets": {
                "bib0315": {
                    "endOffset": 8526,
                    "startOffset": 8523
                }
            },
            "secId": "sec0010",
            "sentence": "Chagas disease has also become \u201cglobalized\u201d with thousands of cases also found in Southern Europe, Australia, and Japan [9].",
            "startOffset": 8403,
            "title": "Global disease and economic burden"
        },
        {
            "endOffset": 13753,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "refoffsets": {
                "bib0380": {
                    "endOffset": 13752,
                    "startOffset": 13745
                },
                "bib0385": {
                    "endOffset": 13752,
                    "startOffset": 13745
                }
            },
            "secId": "sec0020",
            "sentence": "Up to 20% of patients cannot tolerate full treatment courses [22,23].",
            "startOffset": 13684,
            "title": "Current approaches to treatment"
        },
        {
            "endOffset": 20101,
            "parents": [],
            "secId": "sec0040",
            "sentence": "Currently no clinical trials have begun for a Chagas disease vaccine.",
            "startOffset": 20032,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 22397,
            "parents": [],
            "refoffsets": {
                "bib0390": {
                    "endOffset": 22396,
                    "startOffset": 22392
                }
            },
            "secId": "sec0045",
            "sentence": "The Sabin Vaccine Institute Product Development Partnership (Sabin PDP), in collaboration with the Carlos Slim Foundation, the Universidad Aut\u00f3noma de Yucat\u00e1n, the Laboratorios de Biol\u00f3gicos y Reactivos de M\u00e9xico, and the Centro de Investigaci\u00f3n y de Estudios Avanzados del Instituto Polit\u00e9cnico Nacional, is pursuing a therapeutic vaccine comprised of recombinant antigens expressed in yeast or bacteria and formulated with an immunostimulant [24].",
            "startOffset": 21948,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 11553,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "refoffsets": {
                "bib0355": {
                    "endOffset": 11552,
                    "startOffset": 11548
                }
            },
            "secId": "sec0015",
            "sentence": "Ventricular tachycardia and fibrillation leading to sudden death are connected to two-thirds of the mortalities from Chagas disease, followed closely by heart failure and thromboembolism [17].",
            "startOffset": 11361,
            "title": "Natural history and clinical disease"
        },
        {
            "endOffset": 13683,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "secId": "sec0020",
            "sentence": "Additionally, specific treatment for cardiac or digestive manifestations may be required.",
            "startOffset": 13594,
            "title": "Current approaches to treatment"
        },
        {
            "endOffset": 10053,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "secId": "sec0015",
            "sentence": "In its trypomastigote form the parasite then can invade cells such as fibroblasts, macrophages, and epithelial cells, thus largely evading the host's immune system.",
            "startOffset": 9889,
            "title": "Natural history and clinical disease"
        },
        {
            "endOffset": 22536,
            "parents": [],
            "secId": "sec0045",
            "sentence": "In addition, the Sabin PDP collaborates with several other academic groups of investigators to evaluate and test their vaccine candidates.",
            "startOffset": 22398,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 21877,
            "parents": [],
            "refoffsets": {
                "bib0430": {
                    "endOffset": 21875,
                    "startOffset": 21871
                }
            },
            "secId": "sec0045",
            "sentence": "Pre-clinical testing is currently underway for several therapeutic vaccine candidates in mice, dogs, or non-human primates at academic-based institutions (Table 1, [32]).",
            "startOffset": 21707,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 8402,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "refoffsets": {
                "bib0305": {
                    "endOffset": 8401,
                    "startOffset": 8398
                }
            },
            "secId": "sec0010",
            "sentence": "According to the World Health Organization, currently the largest number of people living with Chagas disease are found in focal areas of poverty within Latin America's three wealthiest countries: Argentina (1.5 million), Brazil (1.2 million), and Mexico (0.9 million), while the highest prevalence of the disease (in terms of percentage of the population infected with T. cruzi) is seen in Bolivia (6.104 cases per 100 people) [7].",
            "startOffset": 7970,
            "title": "Global disease and economic burden"
        },
        {
            "endOffset": 22993,
            "parents": [],
            "refoffsets": {
                "bib0435": {
                    "endOffset": 22992,
                    "startOffset": 22988
                }
            },
            "secId": "sec0050",
            "sentence": "According to G-Finder, from 2007 to 2013, just under US$6 million in funding was awarded for Chagas disease vaccine research and development (R&D, preventative and therapeutic), primarily from major public sector funders including the Argentine Ministry of Science, Technology and Productive Innovation, German Federal Ministry of Education and Research (BMBF), Institut Pasteur, and the US National Institutes of Health (NIH) [33].",
            "startOffset": 22561,
            "title": "Likelihood for financing"
        },
        {
            "endOffset": 15787,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "refoffsets": {
                "bib0345": {
                    "endOffset": 15786,
                    "startOffset": 15782
                }
            },
            "secId": "sec0030",
            "sentence": "While both are considered cost-effective, the therapeutic vaccine is considered more cost-effective and cost-saving and therefore more economically dominant [15].",
            "startOffset": 15625,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 23486,
            "parents": [],
            "secId": "sec0050",
            "sentence": "Major philanthropic funders such as the Bill & Melinda Gates Foundation and the Wellcome Trust have not yet prioritized vaccine R&D for the disease, though the Carlos Slim Foundation and the Japanese Global Health Innovative Technology (GHIT) Fund have initiated investment strategies for Chagas disease vaccines, together with other private organizations including the Texas-based Kleberg Foundation, the Southwest Electronic Energy Medical Research Institute, and Texas Children's Hospital.",
            "startOffset": 22994,
            "title": "Likelihood for financing"
        },
        {
            "endOffset": 20470,
            "parents": [],
            "secId": "sec0040",
            "sentence": "However, national regulatory agencies for endemic countries such as the U.S. Food & Drug Administration (FDA), Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios (COFEPRIS, Mexico), European Medicines Agency (EMA) and Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA, Brazil) could be engaged following submission of an Investigational New Drug application.",
            "startOffset": 20102,
            "title": "Technical and regulatory assessment"
        },
        {
            "endOffset": 15410,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0030",
            "sentence": "Therapeutic Chagas disease vaccine in patients with indeterminate infection",
            "startOffset": 15335,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 16408,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0030",
            "sentence": "Chagas disease is an NTD almost exclusively affecting people in poverty and thus there has been an absence of market incentive for pharmaceutical companies to undertake research and development on a vaccine.",
            "startOffset": 16201,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 9439,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "secId": "sec0010",
            "sentence": "Moreover, Chagas also has an important impact on veterinary public health, with canines and sylvatic mammals serving as important reservoir hosts.",
            "startOffset": 9293,
            "title": "Global disease and economic burden"
        },
        {
            "endOffset": 19511,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0035",
            "sentence": "This would be of paramount importance given the approximately 40,000 new cases of Chagas disease that occur in Latin America every year.",
            "startOffset": 19375,
            "title": "General approaches to vaccine development for this disease for low- and middle-income country markets"
        },
        {
            "endOffset": 21603,
            "parents": [],
            "secId": "sec0045",
            "sentence": "Additionally, the combination of various candidate antigens into a multivalent strategy is also being explored.",
            "startOffset": 21492,
            "title": "Status of vaccine R&D activities"
        },
        {
            "endOffset": 19705,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "refoffsets": {
                "bib0280": {
                    "endOffset": 19704,
                    "startOffset": 19698
                },
                "bib0405": {
                    "endOffset": 19704,
                    "startOffset": 19698
                }
            },
            "secId": "sec0035",
            "sentence": "Remarkably, it is estimated that a vaccine would further prevent 10,000 deaths or more annually and would save up to 600,000 DALYs, caused by cardiomyopathy and gastrointestinal disease [2,27].",
            "startOffset": 19512,
            "title": "General approaches to vaccine development for this disease for low- and middle-income country markets"
        },
        {
            "endOffset": 9888,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "secId": "sec0015",
            "sentence": "Typically, the T. cruzi protozoan parasite enters its vertebrate hosts with insect faeces deposited into fresh bite sites, mucosal surfaces or other skin breaks.",
            "startOffset": 9727,
            "title": "Natural history and clinical disease"
        },
        {
            "endOffset": 9292,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "About the disease and pathogen"
                }
            ],
            "refoffsets": {
                "bib0335": {
                    "endOffset": 9291,
                    "startOffset": 9287
                }
            },
            "secId": "sec0010",
            "sentence": "The poor who live in the Western Hemisphere's wealthiest countries, including Argentina, Brazil, Mexico, and the United States are especially neglected, a concept consistent with the tenets of \u201cblue marble health\u201d [13].",
            "startOffset": 9073,
            "title": "Global disease and economic burden"
        },
        {
            "endOffset": 17644,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0030",
            "sentence": "Along these lines, many preclinical models have been employed in the study of Chagas disease, most of which include rodents, dogs, and non-human primates (NHP).",
            "startOffset": 17484,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 15187,
            "parents": [
                {
                    "id": "sec0025",
                    "title": "Overview of current efforts"
                }
            ],
            "secId": "sec0030",
            "sentence": "Hence a third TPP would include the use of a therapeutic vaccine used in conjunction with benznidazole or other newly developed antiparasitic drugs.",
            "startOffset": 15039,
            "title": "Biological feasibility for vaccine development"
        },
        {
            "endOffset": 20960,
            "parents": [],
            "refoffsets": {
                "bib0420": {
                    "endOffset": 20959,
                    "startOffset": 20955
                }
            },
            "secId": "sec0040",
            "sentence": "The parameters used to evaluate proof-of-concept may be similar to those employed for evaluating new small molecule therapeutics including parasitemia [30].",
            "startOffset": 20804,
            "title": "Technical and regulatory assessment"
        }
    ],
    "docId": "S0264410X16300718",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Coreen M.",
                "initial": "C.M.",
                "last": "Beaumier"
            },
            {
                "email": null,
                "first": "Portia M.",
                "initial": "P.M.",
                "last": "Gillespie"
            },
            {
                "email": null,
                "first": "Ulrich",
                "initial": "U.",
                "last": "Strych"
            },
            {
                "email": null,
                "first": "Tara",
                "initial": "T.",
                "last": "Hayward"
            },
            {
                "email": null,
                "first": "Peter J.",
                "initial": "P.J.",
                "last": "Hotez"
            },
            {
                "email": "bottazzi@bcm.edu",
                "first": "Maria Elena",
                "initial": "M.E.",
                "last": "Bottazzi"
            }
        ],
        "doi": "10.1016/j.vaccine.2016.03.074",
        "firstpage": "2996",
        "issn": "0264410X",
        "lastpage": "3000",
        "openaccess": "Full",
        "pub_year": 2016,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Status of vaccine research and development of vaccines for Chagas disease"
    }
}